We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02477826
Brief Title: An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) (CheckMate 227)

First Submitted : June 18, 2015
First Submitted that Met QC Criteria : June 18, 2015
First Posted : June 23, 2015 (Estimate)

Last Update Submitted : February 12, 2018
Last Update Submitted that Met QC Criteria : February 12, 2018
Last Update Posted : February 13, 2018